We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$51.8B
AUM Growth
+$2.19B
Cap. Flow
-$1.04B
Cap. Flow %
-2.01%
Top 10 Hldgs %
17.67%
Holding
2,975
New
68
Increased
781
Reduced
1,984
Closed
53

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$102M
2
XL
XL Group Ltd.
XL
+$28.4M
3
MSFT icon
Microsoft
MSFT
+$26.9M
4
CSCO icon
Cisco
CSCO
+$24.2M
5
GGP
GGP Inc.
GGP
+$24M

Sector Composition

Rank Sector Weight
1 Technology 18.16%
2 Financials 15.87%
3 Healthcare 13.94%
4 Consumer Discretionary 10.36%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEYS icon
2601
Weyco Group
WEYS
$419M
$256K ﹤0.01%
7,278
+20
+0.3% +$726
SYRS
2602
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$255K ﹤0.01%
2,141
-106
-5% -$12.3K
VIA
2603
DELISTED
Viacom Inc. Class A
VIA
$255K ﹤0.01%
6,977
+33
+0.5% +$1.14K
SRGA
2604
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$254K ﹤0.01%
1,883
-21
-1% -$2.9K
INSY
2605
DELISTED
Insys Therapeutics, Inc.
INSY
$254K ﹤0.01%
25,165
-1,725
-6% -$13.8K
AMRC icon
2606
Ameresco
AMRC
$1.36B
$253K ﹤0.01%
18,528
-50
-0.3% -$683
BGFV
2607
DELISTED
Big 5 Sporting Goods
BGFV
$253K ﹤0.01%
49,634
+800
+2% +$4.75K
ARA
2608
DELISTED
American Renal Associates Holdings, Inc
ARA
$253K ﹤0.01%
11,676
-720
-6% -$13.6K
CDZI icon
2609
Cadiz
CDZI
$275M
$252K ﹤0.01%
22,606
+340
+2% +$4.14K
ACNB icon
2610
ACNB Corp
ACNB
$661M
$251K ﹤0.01%
6,738
HONE
2611
DELISTED
HarborOne Bancorp
HONE
$251K ﹤0.01%
23,570
-763
-3% -$8.11K
SMBC icon
2612
Southern Missouri Bancorp
SMBC
$858M
$251K ﹤0.01%
6,731
-50
-0.7% -$1.97K
SMMF
2613
DELISTED
Summit Financial Group, Inc.
SMMF
$251K ﹤0.01%
10,795
+181
+2% +$4.59K
BFST icon
2614
Business First Bancshares
BFST
$1.03B
$250K ﹤0.01%
9,427
+652
+7% +$16.8K
ELF icon
2615
e.l.f. Beauty
ELF
$5.44B
$250K ﹤0.01%
19,603
-1,425
-7% -$19.6K
RM icon
2616
Regional Management Corp
RM
$305M
$250K ﹤0.01%
8,669
-300
-3% -$9.98K
MCB icon
2617
Metropolitan Bank Holding Corp
MCB
$1.15B
$249K ﹤0.01%
6,057
TPCO
2618
DELISTED
Tribune Publishing Company Common Stock
TPCO
$249K ﹤0.01%
15,260
-1,100
-7% -$18.2K
PVLA
2619
Palvella Therapeutics
PVLA
$2.23B
$247K ﹤0.01%
551
-42
-7% -$18.3K
EPM icon
2620
Evolution Petroleum
EPM
$127M
$246K ﹤0.01%
22,271
-1,600
-7% -$16.9K
RNAC icon
2621
Cartesian Therapeutics
RNAC
$257M
$246K ﹤0.01%
528
-32
-6% -$12.9K
RBNC
2622
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$246K ﹤0.01%
9,611
+193
+2% +$5.35K
IX icon
2623
ORIX
IX
$44.8B
$245K ﹤0.01%
+15,125
New +$244K
PBPB
2624
DELISTED
Potbelly
PBPB
$245K ﹤0.01%
19,940
-1,525
-7% -$19.7K
DEO icon
2625
Diageo
DEO
$51.6B
$244K ﹤0.01%
+1,722
New +$247K

Similar funds

RhumbLine Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, RhumbLine Advisers held 2,975 positions worth $51.8B, up 4.4% from $49.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 4.1%. RhumbLine Advisers opened 68 new positions and exited 53, leaving the 2,975-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2018 buy was iShares TIPS Bond ETF: 312,303 shares worth $34.5M.
  • RhumbLine Advisers added most to Williams Companies in Q3 2018, an estimated $16.4M increase.
  • RhumbLine Advisers's biggest Q3 2018 reduction was Apple, cutting an estimated $102M.
  • RhumbLine Advisers fully exited XL Group Ltd. in Q3 2018, selling an estimated $28.4M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $51.8B portfolio in Q3 2018.
  • RhumbLine Advisers opened 68 new positions and closed 53 in Q3 2018.
  • RhumbLine Advisers's portfolio value rose 4.4% quarter-over-quarter to $51.8B.

Based on RhumbLine Advisers's 13F filing for Q3 2018, filed 7 Nov 2018.